Technology
Go Back
PreSize® Neurovascular
Technology
About
Go Back
News
The Team
Our Journey
About
Clinical Evidence
Go Back
Partners
Clinical Trials
Publications
Clinical Evidence
Log In
Contact Us
By clicking “Accept”, you agree to the storing of cookies on your device to enhance site navigation, analyze site usage, and assist in our marketing efforts. View our
Privacy Policy
for more information.
Deny
Accept
Privacy Preferences
Essential cookies
Required
Marketing cookies
Essential
Personalization cookies
Essential
Analytics cookies
Essential
Reject all cookies
Allow all cookies
Save preferences
Press Release
CEO Dr Katerina Spranger awarded the Princess Royal Silver Medal by the Academy of Engineering
Read more
In The Press
AI-driven technology could transform aneurysm treatment
Read more
Press Release
PreSize® trial receives ethics and compliance approval
Read more
Press Release
Oxford Heartbeat secures highly sought-after Innovate UK award
Read more
In The Press
The Telegraph: From Musk to Bezos: the remarkable rise of the executive engineer
Read more
Press Release
PreSize® Neurovascular is launched in the NHS
Read more
Press Release
Interview with Enterprising Oxford
Read more
In The Press
October 12, 2023
Sky News: AI-driven technology could transform aneurysm treatment
PreSize has so far been used in operations involving 375 patients, including in seven hospitals in England and Scotland, and some in Germany, Finland and Ukraine.
In The Press
August 22, 2023
Why Britain is the premier location for AI companies
We look at how London is rivalling San Francisco as a base for start-ups
Press Release
February 4, 2023
Oxford Heartbeat Features on BBC Click
BBC Click features PreSize® Neurovascular in action in the clinical setting…
Press Release
August 15, 2022
First Patient Recruited in Clinical Impact Trial of PreSize® Neurovascular
The trial collecting evidence on the impact of PreSize® Neurovascular’s use in clinical practice has recruited its first patient…
Press Release
November 24, 2021
PreSize® trial receives ethics and compliance approval
Oxford Heartbeat secures ethics and HRA approval to commence clinical trials and test effectiveness of its CE-marked medical software PreSize® Neurovascular in real-world clinical settings...
Previous
Load more
Jan 20, 2022
PreSize® trial receives ethics and compliance approval
Oxford Heartbeat secures ethics and HRA approval to commence clinical trials...
Get in touch to find out more about PreSize®
Contact us